Vivera Pharmaceuticals, Inc. v. Blaine Laboratories, Inc. et al, cacdc:2:2020cv02160

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders;

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management; none of the foregoing items comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis and none of which are comprised of cannabidiol (CBD);

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF [ DAMAGED SKIN AND ] * SCAR * TISSUE; PHARMACEUTICAL PREPARATIONS FOR * SCAR TISSUE * SKIN CARE; PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY *, namely, SCAR TISSUE CARE AND MANAGEMENT; * DERMATOLOGICAL PHARMACEUTICAL PRODUCTS * FOR USE IN SCAR TISSUE CARE AND MANAGEMENT; * DRUG DELIVERY AGENTS IN THE FORM OF GEL-MATRIX FILMS THAT FACILITATE THE DELIVERY OF PHARMACEUTICAL PREPARATIONS * FOR USE IN SCAR TISSUE CARE; * NONE OF THE AFORESAID * FOR USE IN THE TREATMENT OF WOUNDS OR * MARKETED TO PLASTIC OR COSMETIC SURGEONS PERFORMING IMPLANTS OR TISSUE EXPANSION OR DIRECTED FOR USE IN PLASTIC OR COSMETIC SURGERY RELATED TO IMPLANTS OR TISSUE EXPANDERS;

Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials;

Cosmetics; cosmetic preparations for skin care; non-medicated skin care preparations; non-medicated anti-wrinkle and anti-aging skin care preparations; non-medicated anti-aging and anti-wrinkle creams, serums, moisturizers, lotions, toners, cleansers, creams, oils, gels for the skin; anti-aging creams, serums, moisturizers, lotions, toners, cleansers, creams, oils, gels; mon-medicated rejuvenating beauty creams, serums, moisturizers, lotions, toners, cleansers, creams, oils, gels; age spot reducing creams; non-medicated skin care preparations for skin renewal; wrinkle-minimizing cosmetic preparations for topical facial use; cosmetic pads; wipes, cloths or tissues impregnated with a skin cleanser;